Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04906096
Title Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lakshmi Nayak
Indications

relapsed/refractory diffuse large B-cell lymphoma

central nervous system lymphoma

Therapies

GDC-0084

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.